DianaFridlyandMD

PubMed

• Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation Rescues Marrow Failure From Acute Leukemia Therapy in a Patient With Previously Undiagnosed Ligase I...
  Diana M Fridlyand, Shanmuganathan Chandrakasan, Ahmed Aljudi, Waitman K Aumann, Eleanor Westfall, Bailey Kirwan, Elyse W Bryson, Frank G Keller, Staci D Arnold, Andrew...> ;Journal of Pediatric Hematology/oncology. 2023 Jan 1
• Corrigendum to "MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system" [Pharmacology & Therapeutics 213 (2020) 107577].
  Justus M. Huelse, Diana M Fridlyand, Shelton Earp, Deborah DeRyckere, Douglas K. Graham> ;Pharmacology & Therapeutics. 2021 Mar 10
• 21 citations
  MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system.
  Justus M. Huelse, Diana M Fridlyand, Shelton Earp, Deborah DeRyckere, Douglas K. Graham> ;Pharmacology & Therapeutics. 2020 May 14
• 1 citations
  Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor.
  Diana M Fridlyand, Frank G. Keller, Himalee S. Sabnis, Briana C. Patterson, Judith A. Gadde, Jason H. Peragallo, Valérie Biousse, Daniel S. Wechsler> ;Pediatric Hematology and Oncology. 2020 Apr 16
• Erratum: N-tert-Butyl-2-methyl-propanamide. Corrigendum.
  Kelly A. Kluge, Diana M Fridlyand, Cora E. MacBeth, Kenneth I. Hardcastle> ;Acta Crystallographica Section E-structure Reports Online. 2011 Dec 1
• Join now to see all